Could exosomes from umbilical cord cells help heal skin? first safety trial launches

NCT ID NCT07707986

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This Phase 1 study tests whether a liquid containing exosomes from human umbilical cord cells is safe when applied to healthy skin. Ten healthy adults receive the exosome liquid on one small skin area and a placebo liquid on another. Researchers monitor for redness, swelling, itching, or other reactions. This is a first step before testing the liquid on surgical wounds after melanoma removal.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a topical liquid containing exosomes from human umbilical cord cells
What this could lead to
If safe, this exosome liquid could be tested to help heal surgical wounds after melanoma removal, potentially improving scar appearance or recovery.
What could go wrong
This is a very early Phase 1 safety study with only 10 healthy people. It does not test effectiveness, and skin irritation or allergic reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS (HV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • ATMP center of West Kazakhstan Marat Ospanov Medical University

    Aktobe, Aktobe, 030012, Kazakhstan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.